Thymosin Alpha-1: Precision Immune Modulation and Global Clinical Use
An evidence-based review of Thymosin Alpha-1 (TA-1, thymalfasin): biochemistry, mechanisms, clinical trial evidence in viral disease and oncology, safety, and the U.S. 503A Category 2 reclassification.
July 4, 20265 min read
Read Article ›